These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants. Cotton RB Clin Perinatol; 1987 Sep; 14(3):621-33. PubMed ID: 3311542 [TBL] [Abstract][Full Text] [Related]
4. [Ductus arteriosus persistens in the newborn with respiratory distress syndrome. Experience with indomethacin and operative ligation]. Frisch H; Hammerer I; Heinz-Erian P; Gschnitzer F Monatsschr Kinderheilkd; 1982 Jun; 130(6):480-3. PubMed ID: 7132996 [No Abstract] [Full Text] [Related]
5. The inhibition of prostaglandin and prostacyclin synthesis in the clinical management of patent ductus arteriosus. Friedman WF; Kurlinski J; Jacob J; DiSessa TG; Gluck L; Merritt TA; Feldman BH Semin Perinatol; 1980 Apr; 4(2):125-33. PubMed ID: 6990503 [No Abstract] [Full Text] [Related]
6. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus]. Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560 [TBL] [Abstract][Full Text] [Related]
7. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus. Friedman WF; Printz MP; Kirkpatrick SE Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580 [No Abstract] [Full Text] [Related]
8. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants]. Lozano González CH; Holden AM; Hurtado del Río D; Segura MA Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006 [No Abstract] [Full Text] [Related]